NASDAQ:ACXP | Profit Breakdown | Acurx Pharmaceuticals, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$2.31M-$2.25M
2026-03-31-$1.72M-$1.68M
2025-12-31-$1.62M-$1.58M
2025-09-30-$2.03M-$1.99M
2025-06-30-$2.27M-$2.25M
2025-03-31-$2.18M-$2.15M
2024-12-31-$2.79M-$2.78M
2024-09-30-$2.83M-$2.82M
2024-06-30-$4.12M-$4.12M
2024-03-31-$4.38M
2023-12-31-$5.11M
2023-09-30-$3.11M
2023-06-30-$3.45M
2023-03-31-$2.9M
2022-12-31-$3.26M
2022-09-30-$3.54M
2022-06-30-$2.62M
2022-03-31-$2.67M
2021-12-31-$2.63M
2021-09-30-$4.64M
2021-06-30-$4M
2021-03-31-$1.47M
2020-12-31-$1.09M
2020-09-30-$1.31M
2020-06-30-$913,360.00
2020-03-31-$1.28M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$8.09M-$7.97M
2024-12-31-$14.12M-$14.1M
2023-12-31-$14.58M
2022-12-31-$12.09M
2021-12-31-$12.75M
2020-12-31-$4.6M